Similar Papers

Paper Title
Journal
Date
Author
Correlation of Immunoglobulins and Lymphocytes Levels With the Clinical and Microbiological Response of Septic Patients With Gram-Negative Bacteremia
Diamanto Aretha ... Katerina Leukaditou
Journal of Clinical Medicine Research | VOL. 13
Diamanto Aretha, et. al.Diamanto Aretha ... Katerina Leukaditou
01 Jan 2020
Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Inflammatory Bowel Disease
Ingrid Ordás ... William J Sandborn
Clinical Gastroenterology and Hepatology | VOL. 10
Ingrid Ordás, et. al.Ingrid Ordás ... William J Sandborn
16 Jul 2012
Guselkumab (an IL-23–specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis
Howard Sofen ... James G Krueger
Journal of Allergy and Clinical Immunology | VOL. 133
Howard Sofen, et. al.Howard Sofen ... James G Krueger
28 Mar 2014
Evaluation of a novel blood pressure scoring method and its association with clinical response in cancer patients treated with anti-vascular endothelial growth factor therapy.
Mehmet Asim Bilen ... Lacey Mcquinn
Investigational new drugs | VOL. 32
Mehmet Asim Bilen, et. al.Mehmet Asim Bilen ... Lacey Mcquinn
26 Apr 2014
View more papers

More From: EJHaem

Paper Title
Journal
Date
Author
Factors related to mean corpuscular volume in HFE p.C282Y homozygotes.
James C Barton ... Ronald T Acton
EJHaem | VOL. 6
James C Barton, et. al.James C Barton ... Ronald T Acton
01 Feb 2025
HLA-matched related peripheral blood stem cell and bone marrow transplantation with RIC regimens yield comparable outcomes for adult AML.
Takaya Mitsuyoshi ... Masamitsu Yanada
EJHaem | VOL. 6
Takaya Mitsuyoshi, et. al.Takaya Mitsuyoshi ... Masamitsu Yanada
01 Feb 2025
Characteristics of relapsed/refractory diffuse large B-cell lymphoma patients with durable responses to maveropepimut-S, pembrolizumab, and cyclophosphamide: Long-term follow-up from the SPiReL trial.
Arjun Pandey ... Neil L Berinstein
EJHaem | VOL. 6
Arjun Pandey, et. al.Arjun Pandey ... Neil L Berinstein
01 Feb 2025
Combined Proteasome and Autophagy Inhibition in Relapsed/Refractory Multiple Myeloma-A Phase I Trial of Hydroxychloroquine, Carfilzomib, and Dexamethasone.
Tobias S Slørdahl ... Anders Sundan
EJHaem | VOL. 6
Tobias S Slørdahl, et. al.Tobias S Slørdahl ... Anders Sundan
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.